Innovaderma Share Discussion Threads

[come2papa] 26/1/2023 09:44

Yep changed name

[km18] 15/7/2022 11:00

...from a few months ago...

InnovaDerma plc comprises departments engaged in developing clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation. As a result, the firm is focused on hair and beauty. These highly enriching and stimulating initiatives were positively reflected on the firm’s financial prospects, where cash hiked to £1.33m in 2021 from £0.15m in 2020.  Despite the cash rally, the firm’s stock price is undervalued, as illustrated by its low P/E ratio of 14.9x, which is relatively below the consumer staples P/E ratio of 27.31x, hence it is cheaply available for investors to buy the stock. Consequently, it implies that InnovaDerma is trading at a discount with respect to its peers and is likely to soar since its P/B stood at 2.34x.

Brief Analysis:

P/E = 14.9, below sector benchmark.
P/B = 2.34, above industry threshold.
Net cash of £1.33m, higher than prior year....

...from WealthOracle

https://wealthoracle.co.uk/detailed-result-full/IDP/404

[lord loads of lolly] 11/5/2022 15:41

That's as maybe, but there's been no free fall today (at time of writing).

[ali47fish] 11/5/2022 14:02

on my portfolio its down more than 5pc and down ib the last few days

[lord loads of lolly] 11/5/2022 13:32

There's been no free fall today (at time of writing).

[ali47fish] 11/5/2022 12:03

it seems in free fall why?

[parsons4] 08/4/2022 14:05

Just bought some more , had to pay 32.5p , I have been trying all day to buy them cheaper. Shares quite tightly held !

[ali47fish] 08/4/2022 08:25

parson i get you!

[parsons4] 08/4/2022 07:56

Yes but BAR director has invested a total of over £270k in BAR over the last few days at the current low price. He must believe in the new combined group, and since then the shares have stopped falling.

[ali47fish] 07/4/2022 16:32

parson why do you draw that cnclusion-bar has been falling non stop

[parsons4] 07/4/2022 15:54

Well the non-exec director of BAR has purchased 300,000 shares for £233,250 in BAR of course.. At the current share price the bid is worth about 36p. Another Director also bought 50000 shares a few days ago. I think a top-up of IDP is worth while here. It seems the new entity might be going places IMHO

[wskill] 05/4/2022 15:51

Edale Cap seem to have increased anyone know who they are.

[arthur_lame_stocks] 01/4/2022 17:20

BAR is listed on AIM and no it doesn't pay a dividend currently.

[ali47fish] 01/4/2022 17:04

is bar listed on aim and do they pay a dividend? anyone

[se81] 01/4/2022 15:48

yes very surprised the IDP board recommended this offer when they'll be stuck with large shareholdings in the equally illiquid BAR and (on the face of it) won't have a say in how the company is run. Suppose the suspicion is IDP will run out of cash again....and BAR have loads

[ali47fish] 01/4/2022 13:38

i assume that there will be voting for the deal and hope it will be rejected by the majority as bar itself is a failing company

[lord loads of lolly] 31/3/2022 15:20

Call me a cynic, but for BAR to fund this merger largely via its own shares, just before announcing a swing to interim losses looks opportunistic to say the least. Some might say just plain dodgy. They may tout around an acquisition premium versus IDP's share price on 30 March (i.e. pre- merger announcement). But they then go & report interim losses themselves, causing BAR's share price to tank over 26% at time of writing. So much of the so-called acquisition premium has evaporated before it even began. Come on Creightons. You know you want it!

[kemche] 31/3/2022 15:12

Best that can be expected really.

[lord loads of lolly] 31/3/2022 15:07

Not with BAR shareholders it isn't. And presumably not with Mark Ward either, given the huge stake he built in IDP at prices far higher than today's.

[glavey] 31/3/2022 14:01

Hmmm, seems the merger idea is going down well.

[km18] 31/3/2022 10:50

InnovaDerma plc comprises departments engaged in developing clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation. As a result, the firm is focused on hair and beauty. These highly enriching and stimulating initiatives were positively reflected on the firm’s financial prospects, where cash hiked to £1.33m in 2021 from £0.15m in 2020. Despite the cash rally, the firm’s stock price is undervalued, as illustrated by its low P/E ratio of 14.9x, which is relatively below the consumer staples P/E ratio of 27.31x, hence it is cheaply available for investors to buy the stock. Consequently, it implies that InnovaDerma is trading at a discount with respect to its peers and is likely to soar since its P/B stood at 2.34x.

https://wealthoracle.co.uk/detailed-result

Keep up to date with WealthOracle

[mortimer7] 31/3/2022 09:11

Would it not be usual practice for Innovaderma to issue their own RNS as well as the BAR announcement?

[jam4u2] 31/3/2022 07:42

I have to admit I was a bit disappointed to see that the new Mgt team havent been able to deliver... but if I stand back and look at this deal - I have to reluctantly accept its probably the right thing for both companies - I do think there is a ton of 'value' in gaining efficiencies from merging the two operations.

I actually think and have long thought, acquiring your own manufacturing & logistics capabilities is the way to go to properly increase margins ... and BAR have the cash pot to do it.

Let's see...